| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.0901533 |
| P8608 | Fatcat ID | release_homyvpliirbb7m5aae5fkqwoqm |
| P932 | PMC publication ID | 2878279 |
| P698 | PubMed publication ID | 19734235 |
| P5875 | ResearchGate publication ID | 26793286 |
| P2093 | author name string | George C Tsokos | |
| José C Crispín | |||
| P2860 | cites work | Gene Expression Omnibus: NCBI gene expression and hybridization array data repository | Q27860523 |
| Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV | Q28972565 | ||
| Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain | Q34356372 | ||
| Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells | Q34552979 | ||
| Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys | Q34892862 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice | Q36348408 | ||
| Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis | Q36352584 | ||
| Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus | Q36364479 | ||
| CD1d- and MR1-restricted invariant T cells: of mice and men. | Q36548001 | ||
| Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells | Q36726518 | ||
| Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. | Q38313878 | ||
| Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling | Q39773899 | ||
| Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c | Q40846574 | ||
| Fas ligand expression and function in systemic lupus erythematosus | Q41085091 | ||
| Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells | Q42659751 | ||
| The effect of thymectomy on lupus-prone mice | Q43872426 | ||
| T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis | Q44381577 | ||
| Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: production of IL-4. | Q44400621 | ||
| CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor | Q51141123 | ||
| Unique phenotype and distinct TCR V beta repertoire in human peripheral blood alpha beta TCR+, CD4-, and CD8- double negative T cells. | Q52058907 | ||
| CD4-CD8- thymocytes that express the T cell receptor may have previously expressed CD8. | Q52865220 | ||
| Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers | Q56904721 | ||
| Expansion of the population of double negative CD4-8- T alpha beta-cells in the liver is a common feature of autoimmune mice | Q67903296 | ||
| CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated "double-negative" T cells | Q68420303 | ||
| CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis | Q70049950 | ||
| In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells | Q71651086 | ||
| Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver | Q71794021 | ||
| B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production | Q73827831 | ||
| Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression | Q73977252 | ||
| TCR ligation on CD8+ T cells creates double-negative cells in vivo | Q77123351 | ||
| Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus | Q77143628 | ||
| Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death | Q77744353 | ||
| Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells | Q77929230 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| P304 | page(s) | 4675-4681 | |
| P577 | publication date | 2009-09-04 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Human TCR-alpha beta+ CD4- CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype | |
| P478 | volume | 183 |
| Q51067608 | Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity. |
| Q51573067 | Analysis of the inflammatory response in HY-TCR transgenic mice highlights the pathogenic potential of CD4- CD8- T cells. |
| Q40474718 | Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation. |
| Q28388910 | Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens |
| Q35192951 | CD4-like immunological function by CD4- T cells in multiple natural hosts of simian immunodeficiency virus |
| Q39599154 | Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells |
| Q36166566 | Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses |
| Q36051922 | Cooperation between Monocyte-Derived Cells and Lymphoid Cells in the Acute Response to a Bacterial Lung Pathogen |
| Q34080154 | Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice |
| Q93198646 | DNT Cell-based Immunotherapy: Progress and Applications |
| Q36416597 | Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation |
| Q98735477 | Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus |
| Q91868727 | Distinct Features of Canine Non-conventional CD4-CD8α- Double-Negative TCRαβ+ vs. TCRγδ+ T Cells |
| Q34877991 | Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production. |
| Q35716736 | Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions |
| Q64092182 | Double-negative T cells remarkably promote neuroinflammation after ischemic stroke |
| Q37609039 | Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus |
| Q33717456 | Elevated double negative T cells in pediatric autoimmunity |
| Q42285593 | HIV Gag-specific immune response mediated by double negative (CD3(+)CD4(-)CD8(-)) T cells in HIV-exposed seronegative individuals |
| Q37727813 | IL-17 in systemic lupus erythematosus |
| Q37983096 | IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential |
| Q34053939 | IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells |
| Q48228475 | IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus. |
| Q36557519 | Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer |
| Q51752326 | Increased IL-17 and IL-21 producing TCRαβ+CD4-CD8- T cells in Chinese systemic lupus erythematosus patients. |
| Q35747810 | Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus |
| Q34153057 | Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus. |
| Q34614005 | Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus |
| Q26823647 | Inflammatory cytokines in systemic lupus erythematosus |
| Q36951816 | Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus. |
| Q34412837 | Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus |
| Q36177195 | Metabolic regulation of organelle homeostasis in lupus T cells |
| Q26798304 | Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity |
| Q27010174 | Modulatory function of invariant natural killer T cells in systemic lupus erythematosus |
| Q39016144 | New insights into the immunopathogenesis of systemic lupus erythematosus. |
| Q41942913 | On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice. |
| Q33664927 | Pathogenesis of human systemic lupus erythematosus: recent advances |
| Q35557267 | Percentages of CD4+CD161+ and CD4-CD8-CD161+ T cells in the synovial fluid are correlated with disease activity in rheumatoid arthritis |
| Q58710822 | Precision DNA demethylation ameliorates disease in lupus-prone mice |
| Q37019903 | Pro-inflammatory self-reactive T cells are found within murine TCR-αβ(+) CD4(-) CD8(-) PD-1(+) cells. |
| Q35856318 | Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells |
| Q40508654 | Regulation of Interleukin-17 Production |
| Q50069715 | SLE-Associated Defects Promote Altered T Cell Function |
| Q41029099 | Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus. |
| Q40376398 | Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus. |
| Q34079316 | Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade |
| Q96171663 | Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells |
| Q58799147 | T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis |
| Q35836112 | T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity |
| Q35214963 | T cells as a therapeutic target in SLE. |
| Q34075552 | T cells as therapeutic targets in SLE. |
| Q90086507 | TARGETING TARGETED TREATMENT FOR IMMUNE AND NON-IMMUNE KIDNEY DISEASES |
| Q94445506 | Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice |
| Q34785021 | The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response |
| Q35579076 | The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus |
| Q35294513 | The dysregulation of cytokine networks in systemic lupus erythematosus |
| Q35418333 | The role of cytokine in the lupus nephritis |
| Q92051342 | Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps |
| Q28507927 | Tumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasis |
| Q35763036 | cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). |
| Q37272180 | cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease |
Search more.